Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schnorr

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Der Urologe. Ausg. A|September 25, 2003
[An artificial neural network as a tool in risk evaluation of prostate cancer. Indication for biopsy with the PSA range of 2-20 microg/l]C Stephan, B Vogel, H Cammann, et al.
International Journal of Cancer|March 10, 2000
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinomaM Lein, K Jung, C Laube, et al.
International Journal of Cancer|July 31, 2001
Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?K Jung, C Stephan, U Elgeti, et al.
Der Urologe. Ausg. A|December 6, 2005
[Ten years of laparoscopic living kidney donation. From an extravagant to a routine procedure]M Giessing, T F Fuller, S Deger, et al.
The Prostate|May 8, 2001
A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosisM Lein, K Jung, P Hammerer, et al.
Infection Prevention in Practice|May 20, 2024
Hand hygiene perceptions, preferences, and practices among hospital staff in the Dominican Republic in the context of COVID-19: a qualitative studyChristina E Craig, Charles D Schnorr, Cecilia J Then Paulino, et al.
Folia Biologica|December 19, 2003
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome studyE Huland, A Burger, J Fleischer, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Der Urologe. Ausg. A|September 25, 2003
[An artificial neural network as a tool in risk evaluation of prostate cancer. Indication for biopsy with the PSA range of 2-20 microg/l]C Stephan, B Vogel, H Cammann, et al.
International Journal of Cancer|March 10, 2000
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinomaM Lein, K Jung, C Laube, et al.
International Journal of Cancer|July 31, 2001
Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?K Jung, C Stephan, U Elgeti, et al.
Der Urologe. Ausg. A|December 6, 2005
[Ten years of laparoscopic living kidney donation. From an extravagant to a routine procedure]M Giessing, T F Fuller, S Deger, et al.
The Prostate|May 8, 2001
A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosisM Lein, K Jung, P Hammerer, et al.
Infection Prevention in Practice|May 20, 2024
Hand hygiene perceptions, preferences, and practices among hospital staff in the Dominican Republic in the context of COVID-19: a qualitative studyChristina E Craig, Charles D Schnorr, Cecilia J Then Paulino, et al.
Folia Biologica|December 19, 2003
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome studyE Huland, A Burger, J Fleischer, et al.
Pageof 12